Personal information

Other IDs

SciProfiles: 2376087
Scopus Author ID: 56345841600

Activities

Collapse all

Employment (2)

Shandong Provincial Hospital: Jinan, Shandong, CN

2009-07-01 to present | Dr. (Medical Oncology)
Employment
Source: Self-asserted source
Guobin Fu

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2015-12-01 to 2016-12-31 | Postdoctor (Thoracic/Head & Neck Medical Oncology)
Employment
Source: Self-asserted source
Guobin Fu

Education and qualifications (2)

Peking Union Medical College & Chinese Academy of Medical Sciences: Beijing, CN

2004-07-01 to 2009-07-01 | M.D. (Cancer Institute (Hospital）)
Education
Source: Self-asserted source
Guobin Fu

Shandong University: Jinan, Shandong, CN

1999-08-01 to 2004-07-01 | Bachelor of Medicine (Cheeloo College of Medicine)
Education
Source: Self-asserted source
Guobin Fu

Funding (2)

DENND2D的诱导表达对非小细胞肺癌细胞恶性表型影响及其作用机制研究

2019-01-01 to 2021-12-01 | Grant
National Natural Science Foundation of China (Beijing, CN)
URL: https://app.dimensions.ai/details/grant/grant.8873434
GRANT_NUMBER:

81802284
Source: Self-asserted source
Guobin Fu via DimensionsWizard

Taishan Scholar Foundation of Shandong Province

Grant
Government of Shandong Province (Jinan, CN)
Source: Self-asserted source
Guobin Fu

Works (20)

Current status and outlook of medical treatment for KRAS-mutated non-small cell lung cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]
2023 | Journal article
DOI: 10.3760/cma.j.cn112152-20220310-00167
EID:

2-s2.0-85147913855

Part of ISSN: 02533766
Contributors: Xu, W.; Zhuo, X.L.; Liu, L.; Zhao, J.; Lin, X.Y.; Fu, G.B.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation

Oncologist
2023 | Journal article
DOI: 10.1093/oncolo/oyad115
EID:

2-s2.0-85162195334

Part of ISSN: 1549490X 10837159
Contributors: Zhao, J.; Xu, W.; Zhuo, X.; Liu, L.; Zhang, J.; Jiang, F.; Shen, Y.; Lei, Y.; Hou, D.; Lin, X. et al.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer

Journal of Cancer
2023 | Journal article
DOI: 10.7150/jca.77199
EID:

2-s2.0-85156159626

Part of ISSN: 18379664
Contributors: Liu, L.; Li, F.; Zhao, J.; Zhuo, X.; Lai, J.; Wang, J.; Jiang, F.; Xu, W.; Luan, F.; Lin, X. et al.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis.

Frontiers in immunology
2023-09 | Journal article
DOI: 10.3389/fimmu.2023.1251645
PMID: 37799725
PMC: PMC10547882
Contributors: Shu Y; Xu W; Su R; Ran P; Liu L; Zhang Z; Zhao J; Chao Z; Fu G
Source: Self-asserted source
Guobin Fu via Europe PubMed Central

HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons.

Anti-cancer drugs
2023-01 | Journal article
DOI: 10.1097/cad.0000000000001506
PMID: 36689646
Contributors: Jiang F; Lai J; Zhuo X; Liu L; Yang Y; Zhang J; Zhao J; Xu W; Wang J; Wang C et al.
Source: Self-asserted source
Guobin Fu via Europe PubMed Central

Potential Mechanism of Shenling Baizhusan in Disease Treatment：A Review

Chinese Journal of Experimental Traditional Medical Formulae
2022 | Journal article
DOI: 10.13422/j.cnki.syfjx.20221530
EID:

2-s2.0-85138576542

Part of ISSN: 10059903
Contributors: Lai, J.; Zhuo, X.; Jiang, F.; Liu, L.; Wang, J.; Qi, F.; Fu, G.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology.

Chinese medicine
2022-12 | Journal article
DOI: 10.1186/s13020-022-00696-3
PMID: 36528679
PMC: PMC9759852
Contributors: Lai J; Jiang F; Zhuo X; Xu X; Liu L; Yin K; Wang J; Zhao J; Xu W; Liu H et al.
Source: Self-asserted source
Guobin Fu via Europe PubMed Central
grade
Preferred source (of 2)‎

Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics.

Anti-cancer drugs
2022-11 | Journal article
DOI: 10.1097/cad.0000000000001440
PMID: 36378136
Contributors: Lai J; Zhuo X; Yin K; Jiang F; Liu L; Xu X; Liu H; Wang J; Zhao J; Xu W et al.
Source: Self-asserted source
Guobin Fu via Europe PubMed Central
grade
Preferred source (of 2)‎

The allelic regulation of tumor suppressor ADARB2 in papillary thyroid carcinoma.

Endocrine-related cancer
2022-10 | Journal article
DOI: 10.1530/erc-22-0189
PMID: 36305508
Contributors: Li W; Wang T; Fu G; Xu Y; Zhang N; Han L; Yang M
Source: Self-asserted source
Guobin Fu via Europe PubMed Central
grade
Preferred source (of 2)‎

Opportunities and challenges of immune checkpoint inhibitors for extensive‐stage small‐cell lung cancer

Cancer Innovation
2022-08 | Journal article
DOI: 10.1002/cai2.23
Contributors: Jing Zhao; Xiaoli Zhuo; Lei Liu; Zhe Yang; Guobin Fu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.

Journal of cancer research and clinical oncology
2022-07 | Journal article
DOI: 10.1007/s00432-022-04196-7
PMID: 35829744
Contributors: Zhuo X; Guo H; Ma J; Lai J; Liu L; Yin K; Zhao J; Wang J; Jiang F; Xu W et al.
Source: Self-asserted source
Guobin Fu via Europe PubMed Central

Inhibitory effects of combinations of trastuzumab and cytotoxic chemotherapy drugs in HER2-positive gastric cancer

All Life
2021 | Journal article
DOI: 10.1080/26895293.2021.1906330
EID:

2-s2.0-85103382841

Part of ISSN: 26895307 26895293
Contributors: Zheng, S.; Fu, G.-B.; Shen, H.-C.; Liu, Q.; Wang, W.-B.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1α and Caveolin-1.

Cell death & disease
2016-09-22 | Journal article
DOI: 10.1038/cddis.2016.281
PMID: 27899819
PMC: PMC5059879
Source: Self-asserted source
Guobin Fu
grade
Preferred source (of 2)‎

Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.

Human molecular genetics
2016-03-02 | Journal article
DOI: 10.1093/hmg/ddw056
PMID: 26941397
Source: Self-asserted source
Guobin Fu
grade
Preferred source (of 2)‎

The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.

Oncotarget
2016-02-01 | Journal article
DOI: 10.18632/oncotarget.6747
PMID: 26716642
PMC: PMC4868701
Source: Self-asserted source
Guobin Fu

Relationship of genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene and risk and survival in esophagus cancer

Chinese Journal of Cancer Prevention and Treatment
2015 | Journal article
EID:

2-s2.0-84963569987

Part of ISSN: 16735269
Contributors: Shen, R.; Wang, Y.; Sha, D.; Chen, J.-P.; Fu, G.-B.; Wang, C.-X.
Source: Self-asserted source
Guobin Fu via Scopus - Elsevier

The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer.

Carcinogenesis
2014-04-30 | Journal article
DOI: 10.1093/carcin/bgu103
PMID: 24788237
Source: Self-asserted source
Guobin Fu
grade
Preferred source (of 2)‎

Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.

Lung cancer (Amsterdam, Netherlands)
2012-11-20 | Journal article
DOI: 10.1016/j.lungcan.2012.10.012
PMID: 23182661
Source: Self-asserted source
Guobin Fu
grade
Preferred source (of 2)‎

[Identification and Functional Analysis of A Novel Candidate Oncogene RAP2B in Lung Cancer.].

Zhongguo fei ai za zhi = Chinese journal of lung cancer
2009-04-01 | Journal article
DOI: 10.3779/j.issn.1009-3419.2009.04.03
PMID: 20719111
Source: Self-asserted source
Guobin Fu
grade
Preferred source (of 2)‎

Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis.

Journal of the National Cancer Institute
2008-11-11 | Journal article
DOI: 10.1093/jnci/djn379
PMID: 19001599
PMC: PMC3299210
Source: Self-asserted source
Guobin Fu

Peer review (2 reviews for 1 publication/grant)

Review activity for Journal of ethnopharmacology. (2)
How many people are using ORCID?